Farallon Capital Management »

Cerevel Therapeutics Hldng I shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $49M 1.2M 40.89
2024-03-31 $45M 1.1M 42.27

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
UnitedHealth (UNH)
salesforce (CRM)
Iqvia Holdings (IQV)
Exelixis (EXEL)
Aramark Hldgs (ARMK)
Aon Shs Cl A (AON)
Microsoft Corporation (MSFT)
New York Times Cl A (NYT)
Natera (NTRA)
Ishares Tr Ishares Biotech Put Option (IBB)
Nasdaq Omx (NDAQ)
Transunion (TRU)
Intuit (INTU)

View all positions for Farallon Capital Management

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Qube Research & Technologies
Farallon Capital Management
Melqart Asset Management
Goldman Sachs Group
P. Schoenfeld Asset Management
Water Island Capital
Squarepoint Ops
Balyasny Asset Management
Hsbc Holdings
Morgan Stanley

View all funds holding Cerevel Therapeutics Hldng I